Adherence to PRISMA 2020 statement assessed through the expanded checklist in systematic reviews of interventions: A meta‐epidemiological study
Cochrane Evidence Synthesis and Methods · 2024-05 · 2 (5)
DOI: 10.1002/cesm.12074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cochrane Evidence Synthesis and Methods, online erschienen am 23.05.2024. Verfasst von Diego Ivaldi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Department Instituto Universitario Hospital Italiano de Buenos Aires Buenos Aires Argentina. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The preferred reporting items for systematic reviews and meta‐analyses (PRISMA) statement was developed to improve the reporting of systematic reviews (SRs) and meta‐analyses. Due to the suboptimal reporting of the 2009 version, an update was performed and published in 2021. Despite having been evaluated in studies published before its publication, its adherence in SRs of interventions published after 2021 remains unclear.
Objective
To assess PRISMA 2020 statement adherence and its uptake in SRs of interventions.
Methods
We conducted a prospective cross‐sectional study searching MEDLINE (PubMed), including a 10% random sample of all SRs involving human interventions published since January 2022 retrieved by our search process. We did not apply any restrictions. We assessed PRISMA 2020 statement uptake and its adherence using its expanded checklist.
Results
We included 222 out of 945 studies. 67 (30.18%) used PRISMA 2020 statement. None adhered completely, with an average adherence of 42.64% (Min–Max: 14.29%–76.19%). Results and Methods sections had low adherence, with 40.57% (Min–Max: 10.45%–98.51%) and 25.55% (Min–Max: 7.46%–55.22%) respectively. The items with the least adherence were: certainty and reporting bias assessment, excluded studies characteristics and search strategy with 7.46% (5/67), 8.96% (6/67), 10.45% (7/67), and 11.94% (8/67) respectively.
Discussion
As in previous studies, our study showed low adherence, mainly to the methods and results sections. However, our study showed a lower adherence, probably due to the use of the expanded checklist to assessed the tools adherence.
Conclusion
We found a low adherence rate to the PRISMA 2020 expanded checklist. Further PRISMA dissemination and targeted audience training are needed to improve SR reporting and quality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Department Instituto Universitario Hospital Italiano de Buenos Aires Buenos Aires Argentina.
ORCID-Profile: Diego Ivaldi, Mariana Burgos, Luis Garegnani
Zitieren
APA
Ivaldi, D., Burgos, M., Oltra, G., Liquitay, C. E., & Garegnani, L. (2024). Adherence to PRISMA 2020 statement assessed through the expanded checklist in systematic reviews of interventions: A meta‐epidemiological study. Cochrane Evidence Synthesis and Methods, 2(5). https://doi.org/10.1002/cesm.12074
Vancouver
Ivaldi D, Burgos M, Oltra G, Liquitay CE, Garegnani L. Adherence to PRISMA 2020 statement assessed through the expanded checklist in systematic reviews of interventions: A meta‐epidemiological study. Cochrane Evidence Synthesis and Methods. 2024;2(5). doi:10.1002/cesm.12074
BibTeX
@article{Ivaldi2024,
author = {Ivaldi, Diego and Burgos, Mariana and Oltra, Gisela and Liquitay, Camila E and Garegnani, Luis},
title = {Adherence to PRISMA 2020 statement assessed through the expanded checklist in systematic reviews of interventions: A meta‐epidemiological study},
journal = {Cochrane Evidence Synthesis and Methods},
year = {2024},
volume = {2},
number = {5},
doi = {10.1002/cesm.12074}
}
EUVIMED